0001171843-17-005224.txt : 20170823 0001171843-17-005224.hdr.sgml : 20170823 20170823210017 ACCESSION NUMBER: 0001171843-17-005224 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170821 FILED AS OF DATE: 20170823 DATE AS OF CHANGE: 20170823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDENBERG CYNTHIA L CENTRAL INDEX KEY: 0001202016 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 171048110 MAIL ADDRESS: STREET 1: C/O XIMMUNOMEDICS INC STREET 2: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN CYNTHIA L DATE OF NAME CHANGE: 20021029 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 4 1 f4_cynthiagoldenberg082317.xml OWNERSHIP DOCUMENT X0306 4 2017-08-21 0 0000722830 IMMUNOMEDICS INC IMMU 0001202016 GOLDENBERG CYNTHIA L C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 0 0 0 Common Stock 2017-08-21 4 S 0 20000 8.9713 D 858219 D Common Stock 2017-08-22 4 S 0 10000 9.50 D 848219 D Common Stock 2017-08-23 4 S 0 10000 9.50 D 838219 D Common Stock 5128014 I See Footnote The price in column 4 is a weighted average price. The prices actually received in this transaction range from $8.85 to $9.09. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. Includes a total of 635,935 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, a director of the issuer and the Issuer's Chief Scientific Officer and Chief Patent Officer. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein. /s/ Cynthia L. Goldenberg 2017-08-23